Reagents for testing.

Ended Awarded

Contract number
HT009026FG1030045
Awardee
Awarding agency
Obligated
$24,331

Award facts

Contract value 100% obligated
$24,331.14 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
334516 Analytical Laboratory Instrument Manufacturing
PSC
6550 In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Set-aside
No set-aside
Competition
Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Castleton, IN 46256, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call to Roche Diagnostics Corporation for reagents for testing, with a ceiling value of $24,331.14 and a firm fixed price structure. The contract was awarded on October 8, 2025, with an ultimate completion date of September 30, 2026, and will be performed in Castleton, Indiana. This award represents a child contract under a larger vehicle, leveraging Roche Diagnostics' established GSA Schedule contracts for in vitro diagnostics and reagents, which enable federal healthcare agencies to access pre-negotiated pricing for diagnostic testing supplies.

Roche Diagnostics Corporation, a foreign-owned manufacturer specializing in in vitro diagnostics and laboratory reagents, is a primary supplier of diagnostic solutions to the Department of Defense and Veterans Affairs. The company holds multiple significant indefinite delivery contracts and BPAs with federal healthcare agencies, providing molecular diagnostic testing equipment, clinical chemistry analyzers, immunochemistry testing, and specialized reagents for infectious disease and chronic condition detection. This award includes no set-aside designation and reflects Roche's continued competition in the open federal marketplace to support medical testing and patient care across the military and veterans healthcare systems.

Quick answers

Who was awarded contract HT009026FG1030045?

HT009026FG1030045 was awarded to Roche Diagnostics Corporation by Defense Health Agency (Department of Defense) on October 8, 2025.

How much is contract HT009026FG1030045 worth?

The government has obligated $24,331 on HT009026FG1030045.

Is contract HT009026FG1030045 an order under another contract?

Yes. HT009026FG1030045 is a BPA call under FA301625A0005, a blanket purchase agreement.

Was contract HT009026FG1030045 competed?

The extent of competition for HT009026FG1030045 was competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award